Leonardo DRS (DRS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
24 Feb, 2026Executive summary
Achieved double-digit organic revenue growth of 13% in 2025, driven by strong customer demand, record bookings, and a book-to-bill ratio at or above 1.2x for the fourth consecutive year, with a year-end backlog of $8.7 billion providing strong visibility into 2026 growth.
Delivered 19% growth in full-year free cash flow, with net earnings of $278 million for the year and $102 million in Q4.
Secured a landmark position on the SDA Tracking Layer Tranche 3 program and a $100 million, 10-year quantum laser IP license agreement, contributing $73 million to 2025 revenue and Adjusted EBITDA.
Leadership transition with John Baylouny appointed CEO, emphasizing innovation and operational excellence, and Sally Wallace as COO.
Financial highlights
Q4 2025 revenue was $1.1 billion, up 8% year-over-year; full year revenue reached $3.648 billion, up 13% organically.
Adjusted EBITDA was $158 million in Q4 (up 13%) and $453 million for the year (up 13%).
Margins were 14.9% in Q4 and 12.4% for the full year, with margin flat year-over-year due to higher R&D investment and material cost growth.
Diluted EPS and Adjusted Diluted EPS for Q4 were $0.38 and $0.42, and for the full year $1.03 and $1.15, respectively.
Free cash flow for the year was $227 million, with a net cash position and strong liquidity at year-end.
Outlook and guidance
2026 revenue guidance is $3.85–$3.95 billion, implying 6–8% organic growth, supported by strong backlog.
Adjusted EBITDA expected at $505–$525 million, with margin improvement of 70–90 basis points year-over-year.
Adjusted Diluted EPS guidance is $1.20–$1.26 per share; free cash flow conversion expected at 80% of adjusted net earnings.
Effective tax rate for 2026 forecasted at 18.5%.
CapEx projected to be just under 5% of revenue in 2026, with continued focus on capacity expansion and modernization.
Latest events from Leonardo DRS
- Q2 2024 revenue up 20%, backlog at $7.9B, and guidance raised on strong demand.DRS
Q2 20242 Feb 2026 - Q1 2025 saw 16% revenue growth, record backlog, and reaffirmed strong full-year guidance.DRS
Q1 202522 Jan 2026 - Q3 revenue up 16%, net earnings up 21%, and backlog reached a record $8.3B.DRS
Q3 202417 Jan 2026 - Record bookings, margin expansion, and strong backlog support continued growth in 2025.DRS
Q4 20248 Jan 2026 - Board seeks approval for director elections, pay, auditor, and charter changes, emphasizing governance.DRS
Proxy Filing2 Dec 2025 - Board recommends voting for all proposals, including charter amendment and auditor ratification.DRS
Proxy Filing2 Dec 2025 - Key votes include director elections, auditor ratification, and removal of supermajority rules.DRS
Proxy Filing2 Dec 2025 - Q2 2025 saw double-digit revenue and profit growth, with raised guidance and margin pressures.DRS
Q2 20251 Nov 2025 - Q3 2025 revenue up 18% to $960M, net earnings up 26%, backlog at $8.9B, guidance raised.DRS
Q3 202529 Oct 2025